This piece of work covers thirteen (13) AIDS assistance programs sites over the period 1st January 2008 to 31st December 2015. The study is retrospective, descriptive, and cross-sectional based on 292 clinical cases of HIV infected children aged between 0 and 14 years old. A regional committee was charged to validate antiretroviral treatment (ART) prescriptions on a weekly basis. We have also used data from the regional committee register. HIV infected children represent 5.1% of casework on ART. The average starting age for ART was 4.5 years (1 -180 months) with a sex ratio (Male/Female) of 0.9. The clinical classifications according to WHO guidelines were: Stage III (52.3%) and Stage IV (20.3%). The most frequent opportunistic infections were: wasting (40.12%), digestive candida infection (29.0%), acute respiratory infections (22.8%) and skin diseases (17.9%). The HIV type 1 was detected on all of the children (100%). The average rate of CD4 at the beginning of the ART was 552.98 cells/mm 3
Background
In 2014, 36.9 million people were living with Human Immunodeficiency virus (HIV) worldwide [1] . At the end of 2013, only 23% of needing children (<15 years) against 37% of adults were taking ART (Antiretroviral therapy) in the developing world. About 90% of these children come from Sub-Saharan African countries [2] . However, new pediatric infections decreased to 58% from 2000 to 2014 worldwide [1] . Also UNAIDS elaborated a strategy to decrease those prevalence rates further by 2020 with 3 targets: 90% of HIV infected children will be tested and their serological status be known by their parents; 90% of infected children will take ART over their lifetime; and 90% of those who are taking treatment should attain an undetectable viral charge [1] .
In Togo, the HIV prevalence among the general population is 2.5% [3] . The children on ART (7% of casework on national records) were 3058 in 2015 [4] .
Despite the rapid expansion of the Prevention of Mother To Child Transmission of HIV (PMTCT) services and the improvement of ART coverage on children population, the pediatric HIV infection care is insufficient in Togo. During the last fifteen years, PMTCT helped to prevent nearly 1,400,000 children from developing AIDS [2] . But stock-out of Polymerase Chain Reaction (PCR) tests, high rate of pregnant seropositive women lost of view in PMTCT program, lack of pediatricians, insufficiency of child care programs integration and the low task shifting limit the pediatric ART coverage improvement [4] . Several studies on the infected children have been performed in Togo [5] [6] , but none of them focus on the Central Region. Therefore, the purpose of this investigation is to describe epidemiological, clinical, biological and therapeutic characteristics of HIV infected children in the Central Region of Togo from 2008 to 2015.
Methodology
Togo is a western African country, situated in Gulf of Guinea. Its population is about 6,191,155 habitants, with 51.4% of Women in 2010 [7] . The country is divided into five (5) administrative and six (6) health regions. The following work relates to the Central Region. Its population was about 696,020 habitants in 2015 for a geographical area of 13,307 km 2 [8] . The city of Sokodé, the administrative headquarter of that region is located 340 kilometers to the North of Lomé, the capital city of Togo. All the AIDS assistance programs sites (n = 13), looking af- 
Results
• Epidemiologic estimates The average age of ART initiation was 4.5 years (2 months -180 months).
Children under 5 years represented nearly one third (61.3%) of the sample.
The sex-ratio was 0.9 (47% male and 53% female).
The The year 2010 (51 out of 292, 17.5%) saw the higher number of patients.
The majority of patients (77.4%), were living in the health district of Tchaoudjo with Sokodé acting as the headquarter.
• Clinical findings
According to WHO classification, the clinical stages III (52.7%) and IV (20.3%) were the most frequent.
Wasting (40.1%), digestive candida infection (29.0%), acute respiratory infection (22.8%) and skin diseases (17.9%) were the main opportunistic affections.
The HIV/tuberculosis co-infection has represented 6.7%.
• Biological indicators
The type 1 of VIH was found for all children (100%). Twenty one of them have had a PCR positive (under 18 months) (7.2%). The average rate of CD4 at the beginning of the ART was 552.98 ± 131.40 cell/mm 3 (N = 241). A moderate to severe immunosuppression was observed (respectively 44.8% and 19.9%).
The pre-ART tests were in the norms (Table 2 ).
• Therapeutic approach
The First-line ART was essentially NEVIRAPINE + LAMIVUDINE + STAVUDINE (46.2%), then NEVIRAPINE + LAMIVUDINE + ZIDOVUDINE (27.7%) and LOPINAVIR-RITONAVIR + LAMIVUDINE + ABACAVIR (9.6%).
• Risk factors on ART Factors associated with age were CD4 rate (p < 0.0001) and hemoglobin rate (p < 0.0003). Two factors (age and alanine aminotransferase rate) were associated with ART initiation using multivariate model. 0.13 represented the risk factor for initiating a protease inhibitor regime up to 2 years against under 2 years. [7] .
The HIV infected children were living mostly in district of Tchaoudjo and the town of Sokodé (77.4%). Overall, in the wider population of Togo, the prevalence of HIV is higher in urban zones (3.5%) than in rural ones (1.6%) [3] . support. This coaching conducted monthly by two regional pediatricians to support peripheral providers was known to strengthen child testing and improve clinical care [4] . So pediatric clinical mentorship should be strengthening in the Central Region of Togo.
According to WHO classification, the clinical stages III (52.7%) and IV (20.3%) were the most frequent. This late diagnosis on the children in the inves- Wasting constitutes the first opportunistic disease observed in our work.
Those rates are lower than SAGBO's results (53.5%), but higher than OJUKWU results in Nigeria (33.8%) in 2007 [22] and DIARRASSOUBA ones (21.1%) in
Côte d'Ivoire [15] . In Kenya in 2008, wasting was found on the 40% of inpatient infected children and led to up to half of morbidity link to AIDS disease on child [23] . Many reasons can explain the high prevalence of wasting among HIV infected children: insufficient food supply, anorexia, mouth ulceration, bad absorption, diarrhea or enteropathy due to HIV and the increase of metabolism link to opportunistic disease and HIV itself [24] .
Acute respiratory infections are common opportunistic affections. The clinical signs and X-Ray were simple techniques used for the diagnosis. The germs responsible could not be isolated. Pneumonia was largely describe by others authors [25] [26] [27] . The pneumonia in pediatric HIV infection were often due to gram negative bacteria, Pneumocystis jiroveci and mycobacterium tuberculosis [28] . Bronchoalveolar lavage, required for the diagnosis of Pneumocystis jiroveci is not available in the Central Region of Togo.
Fungal infection as digestive candida is also observed as frequent HIV opportunistic affection among HIV infants: 19.8% for SAGBO [14] and 38.2% for OJUKWU [22] . In 2007, OJUKWU have identified buccal candida infection as a major factor for likelihood of HIV infection beyond 6 weeks of life. The digestive canal is one of the principal organs with an abundance of immuno-competent cells [26] .
The type 1 of VIH was found for all children (100% [17] in Benin, DIACK in Senegal [21] (57.1%) and SAGBO (74%) [19] .
The average rate of hemoglobin (10.9 g/dl) was higher than the one in the Maritime Region (9.73 g/dl) [5] , in the Southern part of Togo. In fact, wasting is known to be more prevalent in this southern region [3] . Anemia was found in the majority of HIV infected person with multifactor etiologies [29] . It is frequent in pediatrics population in Africa in general. In Togo and in Senegal, re- The remaining biological results were globally in the standard norms (creatinine, ALAT).
The-first line regimen NEVIPARINE + LAMIVUDINE + STAVUDINE was the most prescribed ART combination (46.2%). Idem in the Maritime Region in Togo before 2011 (94.8%) [5] and in Benin before 2010 (90.5%) [14] . In fact, since 2010, WHO guidelines recommended replacing STAVUDINE by ZIDOVUDINE because of many sides effects such as peripheral neuropathies.
So the long period of our study extending from 2008 to 2015 explains the importance of NEVIPARINE+LAMIVUDINE+ZIDOVUDINE (27.7%) regimen.
ART providers were not familiar with the regimen LOPINAVIR -RITONAVIR + LAMIVUDINE + ABACAVIR in the first line (9.6%), even though it had been recommended since 2010 with mothers receiving NEVIRAPINE in PMTCT services [9] [10].
• Risk factors on ART Factors associated with age were CD4 rate (p < 0.0001) and hemoglobin rate (p < 0.0003). Two factors (age and alanine aminotransferase rate) were associated with ART initiation using multivariate model. 0.13 represented the risk factor for initiating a protease inhibitor regime up to 2 years against under 2 years. National guidelines recommend a protease inhibitor regime under 3 years because of the use of NEVIRAPINE in PMTCT program [9] [10]. According to alanine aminotransferase rate, the difference between ART regimes were not significant.
Conclusion
Pediatric HIV diagnosis remains delayed in the Central Region of Togo (average age for ART initiation 4.5 years) with advanced clinical stages (72.6%) and severe immunosuppression (44.8%). The initial ART was essentially NEVIRAPINE + LAMIVUDINE + STAVUDINE (46.2%). The achievement of UNAIDS 90-90-90 targets in 2020 appears hypothetic. However, a pediatric HIV national plan of acceleration has just been elaborated in March 2017. Strategies with high evidence as the early initiated diagnosis (EID), provider initiated testing and counselling (PITC) for each child attending health facilities and clinical mentorship have vigorously been strengthened. The key intervention should be the ART task shifting process started in 2015 in Togo.
